Please use this identifier to cite or link to this item:
Title: Novel therapeutic approach for cutaneous T-Cell lymphoma
Authors: Low, Jian Hui
Keywords: DRNTU::Science
Issue Date: 2016
Abstract: Cutaneous T-cell lymphoma (CTCL) is a skin-localizing, non-Hodgkin lymphoma arising from the malignant transformation of skin-homing CD4+ T-cells. The primary drivers of CTCL pathogenesis is aberrant signalling of the JAK/STAT3 pathway, resulting in defective apoptosis and increased cellular proliferation. In this study, we employed antisense oligonucleotide (ASO) technology to specifically target STAT3 in various CTCL cell lines, which have been reported to be notoriously difficult to transfect without the use of transfection agents. We demonstrated successful gene silencing of STAT3 in vitro with the use of chemically modified ASO, and specific knockdown of STAT3 induced various morphological markers indicating apoptotic cell death. These results indicate that self-delivering STAT3-targeting ASO could serve as an alternative approach for CTCL treatment.
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:SBS Student Reports (FYP/IA/PA/PI)

Files in This Item:
File Description SizeFormat 
Low Jian Hui_U1340779K_FYP Thesis.pdf
  Restricted Access
FYP Thesis737.31 kBAdobe PDFView/Open

Page view(s)

Updated on May 18, 2021

Download(s) 50

Updated on May 18, 2021

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.